本頁面由Tiger Trade Technology Pte. Ltd.提供服務

再鼎醫藥

24.89
+0.09000.36%
成交量:83.18萬
成交額:2,089.31萬
市值:27.96億
市盈率:-14.62
高:25.32
開:24.90
低:24.78
收:24.80
52周最高:34.72
52周最低:15.96
股本:1.12億
流通股本:9,711.04萬
量比:1.13
換手率:0.86%
股息:- -
股息率:- -
每股收益(TTM):-1.7030
每股收益(LYR):-1.6026
淨資產收益率:-26.91%
總資產收益率:-14.75%
市淨率:4.61
市盈率(LYR):-15.53

資料載入中...

2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/03

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/23

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/07/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/26

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/06/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]